Affordable Access

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.

Authors
Type
Published Article
Journal
The Journal of Urology
0022-5347
Publisher
Elsevier
Publication Date
Volume
172
Issue
5 Pt 1
Pages
1871–1876
Identifiers
PMID: 15540741
Source
Medline

Abstract

Statistics

Seen <100 times